The Pre-operative Pathway in Pancreatic Head Malignancy-assessment of the Diagnostic Accuracy of Staging CT Scan
NCT02296736 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 422
Last updated 2019-09-04
Summary
Our aim is to assess the ability of scans to distinguish the organ of origin of pancreatic head malignant tumours and to predict the resectability based on the preoperative imaging. To achieve this, a retrospective review of the preoperative CT scans will be conducted for all patients with pancreatic head malignancy treated at the Peninsula Hepato-Pancreatico-Biliary (HPB) cancer unit between January 2006 till January 2014.
Conditions
- Cancer of Pancreas
Interventions
- RADIATION
-
Computerised tomography (CT) scan
Retrospective review of CT scans
Sponsors & Collaborators
-
University Hospital Plymouth NHS Trust
lead OTHER
Principal Investigators
-
David Stell, MBBS, PhD · University Hospital Plymouth NHS Trust
-
Bassem Amr, MBBS · University Hospital Plymouth NHS Trust
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-10-31
- Primary Completion
- 2017-09-30
- Completion
- 2017-09-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Circulating Tumor Cells in Operative Blood
NCT02150746 ·Status: COMPLETED
-
Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer
NCT06600906 ·Status: RECRUITING
-
Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma
NCT05262855 ·Status: COMPLETED ·Phase: PHASE2
-
Slide Interpretation or Standard Surgical Pathology in Assessing Margin Status in Patients With Pancreatic Cancer Undergoing Surgery
NCT01646697 ·Status: COMPLETED ·Phase: NA
-
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
NCT04275557 ·Status: RECRUITING
-
Two Stage Study Of Single Dose PEGPH20 And Cetuximab In Patients With Pancreatic Adenocarcinoma Prior To Surgical Resection
NCT02241187 ·Status: COMPLETED ·Phase: NA
-
Defining a Vascular Phenotype of Pancreatic Ductal Adenocarcinoma With CT Perfusion Using Quantitative Radiomics
NCT05669287 ·Status: UNKNOWN ·Phase: NA
-
Systemic Therapy and Chemoradiation in Advanced Localised Pancreatic Cancer - 2
NCT02024009 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Multi-omics Characterization of Pancreatic Neuroendocrine Tumors and Carcinomas
NCT05234450 ·Status: UNKNOWN
-
Gene Expression in Pancreatic Cancer
NCT03531125 ·Status: TERMINATED
-
A Prospective Translational Tissue Collection Study in Early and Advanced Pancreatic Ductal Adenocarcinoma and Pancreatic Neuroendocrine Tumours to Enable Further Disease Characterisation and the Development of Potential Predictive and Prognostic Biomarkers
NCT03840460 ·Status: UNKNOWN
-
Neoadjuvant Chemotherapy and Stereotactic Radiosurgery to Pancreatectomy for Patients With Borderline Resectable Pancreatic Cancer
NCT03199144 ·Status: WITHDRAWN ·Phase: PHASE2
-
Changes in Biomarkers From Blood Over Time in Patients With Pancreatic Adenocarcinoma
NCT02974764 ·Status: COMPLETED
-
Prognostic and Predictive Biomarkers of Therapeutic Response in Pancreatic Tumors
NCT01692873 ·Status: COMPLETED ·Phase: NA
-
The Detection of CTCs in Patients With Pancreatic Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment.
NCT02406846 ·Status: COMPLETED
-
Evaluation of an Early Radiomic Signature in Patients With Metastatic Pancreatic Adenocarcinoma Treated With First-line Chemotherapy
NCT07243288 ·Status: ACTIVE_NOT_RECRUITING
-
The Role of the Tumor Microenvironment of Pancreatic Cancer to Predict Treatment Outcome
NCT01989000 ·Status: COMPLETED ·Phase: NA
-
Study of Neoadjuvant Treatment in Patients With Pancreatic Cancer That is Potentially Resectable
NCT01531712 ·Status: TERMINATED ·Phase: PHASE2
-
Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery
NCT00408564 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Gemcitabine and Oxaliplatin With Radiation Therapy in Patients With Pancreatic Cancer
NCT00456599 ·Status: COMPLETED ·Phase: PHASE2
-
Correlation of Portal and Peripheral Venous ctDNA in Pancreatic Adenocarcinoma
NCT06478056 ·Status: COMPLETED ·Phase: NA
-
Magnetic Resonance Imaging for Better Selection of Pancreatic Cancer Patients for Surgery: A Randomized Clinical Trial
NCT05253313 ·Status: UNKNOWN ·Phase: NA
-
Diagnosis and Survival Prediction of Pancreatic Cancer by Machine Learning of Image Data
NCT05313854 ·Status: UNKNOWN
-
Phase II Study of Chemo-Radiotherapy in Patients With Resectable and Borderline Resectable Pancreatic Cancer
NCT02243358 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Interobserver Agreement on the Resectability Status of Patients With a Pancreatic Cancer
NCT03673423 ·Status: UNKNOWN